SEC Form 4 · accession 0001209191-15-024768
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yao Wenqing
Officer — EVP, Discovery Medicinal and P
Period of report
Mar 10, 2015
Accepted (ET)
Mar 10, 2015 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 10, 2015 | M | 892 | $18.32 | A | 40,208 | D | |
| Common Stock | Mar 10, 2015 | M | 3,512 | $17.79 | A | 43,720 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $18.32 | Mar 10, 2015 | M | 892 | D | — | Feb 8, 2020 | Common Stock | 892 | 6,566 | D |
| Incentive Stock Option (right to buy)F2 | $17.79 | Mar 10, 2015 | M | 3,512 | D | — | Jan 18, 2019 | Common Stock | 3,512 | 0 | D |
Explanation of responses
- F1Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- F2Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.